Jonathan A. Keller, PharmD, JD; Megan Herber, MPH; Larissa Morgan, JD, MBE

home / authors / jonathan-a-keller-pharmd-jd-megan-herber-mph-larissa-morgan-jd-mbe

Articles

DEA’s Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community

April 28th 2023

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders

Published: January 18th 2016 | Updated: October 18th 2024

10 Pharmacy Quotes That Will Make You Rethink the Profession

Published: September 22nd 2015 | Updated: October 14th 2024

Gabapentin Differs From Pregabalin in Several Key Ways

Published: August 30th 2024 | Updated: November 21st 2024

Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report

Published: October 8th 2024 | Updated: November 21st 2024

What Drug Rates Are Reported in Price Transparency Data?

Image Credit: Syda Productions - stock.adobe.com

Published: October 7th 2024 | Updated: November 21st 2024

What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Jonathan A. Keller, PharmD, JD; Megan Herber, MPH; Larissa Morgan, JD, MBE

Articles

Latest Updated Articles